SSH -SAGINAW INC. — History
CCN 232033 | 3-year financial timeline | COVID resilience: 27/100
🛡️ Public data only — no PHI permitted on this instance.
$16M
Latest Revenue (FY2022)
-5.5%
Revenue CAGR (3yr)
9.9%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $18M | $14M | $16M | +10.4% | -5.5% |
| Operating Expenses | $14M | $14M | $14M | +2.7% | -0.4% |
| Operating Margin | 18.9% | 3.1% | 9.9% | +217.6% | -27.7% |
| Net Income | $3M | $0M | $2M | +250.5% | -31.7% |
| Licensed Beds | 32 | 32 | 32 | +0.0% | +0.0% |
| Total Patient Days | 8,517 | 7,885 | 7,413 | -6.0% | -6.7% |
| Medicare Day % | 40% | 37% | 36% | -4.0% | -5.4% |
| Medicaid Day % | 2% | nan% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 27/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -10.8% ($18M → $16M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▼ Declining
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-5.5%
This Hospital
+7.6%
State Avg
Latest Margin
9.9%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $15M | 5.4% |
| FY2024 (proj) | $14M | 0.8% |
| FY2025 (proj) | $13M | -3.7% |